Skip to main content
TipRanks
Go Ultimate75% OFF

Mark Haberlin Insider Profile

4 Followers

Mark Haberlin, Director at Australian Clinical Labs Ltd, holds 47.50K shares in Australian Clinical Labs Ltd (Ticker: AU:ACL), holds 42.29K shares in Abacus Property Group (Ticker: AU:ABG). Most recently, Mark Haberlin Bought ― shares of Australian Clinical Labs Ltd on Nov 22, 2021 for an estimated value of AU$98.99K.

Mark Haberlin's Trading History

ACL
Australian Clinical Labs Ltd
Nov 22, 2021DirectorInformative Buy98.99KAU$159.13K
ABG
Abacus Property Group
Jan 04, 2021DirectorInformative Buy21.15KAU$36.37K

You May Also Like

Mark Haberlin insider profile FAQ

What is the percentage of profitable transactions made by Mark Haberlin?
The percentage of profitable transactions made by Mark Haberlin is 40%.
What is the average return per transaction made by Mark Haberlin?
The average return per transaction made by Mark Haberlin is 8.00%.
What stocks does Mark Haberlin hold?
Mark Haberlin holds: AU:ACL, AU:ABG stocks.
What was Mark Haberlin’s latest transaction?
Mark Haberlin’s latest transaction was an Informative Buy of AU$98.99K.
What was Mark Haberlin's most profitable transaction?
Mark Haberlin’s most profitable transaction was an Informative Buy of AU:ABG stock on January 4, 2021. The return on the trade was 45.40%.
What is Mark Haberlin's role in Australian Clinical Labs Ltd?
Mark Haberlin's role in Australian Clinical Labs Ltd is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.